ChemMedChemPub Date : 2023-09-14DOI: 10.1002/cmdc.202300366
Dmitry A. Makarov, Dr. Sergey D. Negrya, Maxim V. Jasko, Dr. Inna L. Karpenko, Dr. Pavel N. Solyev, Dr. Vladimir O. Chekhov, Dr. Dmitry N. Kaluzhny, Dr. Olga V. Efremenkova, Byazilya F. Vasilyeva, Dr. Alexander O. Chizhov, Dr. Darya A. Avdanina, Dr. Alexander A. Zhgun, Prof. Sergey N. Kochetkov, Dr. Liudmila A. Alexandrova
{"title":"5-Substituted Uridines with Activity against Gram-Positive Bacteria","authors":"Dmitry A. Makarov, Dr. Sergey D. Negrya, Maxim V. Jasko, Dr. Inna L. Karpenko, Dr. Pavel N. Solyev, Dr. Vladimir O. Chekhov, Dr. Dmitry N. Kaluzhny, Dr. Olga V. Efremenkova, Byazilya F. Vasilyeva, Dr. Alexander O. Chizhov, Dr. Darya A. Avdanina, Dr. Alexander A. Zhgun, Prof. Sergey N. Kochetkov, Dr. Liudmila A. Alexandrova","doi":"10.1002/cmdc.202300366","DOIUrl":"10.1002/cmdc.202300366","url":null,"abstract":"<p>The emergence of drug-resistant strains of pathogenic microorganisms necessitates the creation of new drugs. A series of uridine derivatives containing an extended substituent at the C-5 position as well as C-5 alkyloxymethyl, alkylthiomethyl, alkyltriazolylmethyl, alkylsulfinylmethyl and alkylsulfonylmethyl uridines were obtained in order to explore their antimicrobial properties and solubility. It has been shown that new ribonucleoside derivatives have an order of magnitude better solubility in water compared to their 2′-deoxy analogues and effectively inhibit the growth of a number of Gram-positive bacteria, including resistant strains of <i>Mycobacterium smegmatis</i> (MIC=15–200 μg/mL) and <i>Staphylococcus aureus</i> (MIC=25–100 μg/mL). Their activity is comparable to that of some antibiotics used in medicine.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"18 21","pages":""},"PeriodicalIF":3.4,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10236088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2023-09-13DOI: 10.1002/cmdc.202300348
Dr. Yu Mikame, Honoka Eshima, Haruki Toyama, Juki Nakao, Misaki Matsuo, Dr. Tsuyoshi Yamamoto, Prof. Yoshiyuki Hari, Prof. Jun A. Komano, Prof. Asako Yamayoshi
{"title":"Development and Crosslinking Properties of Psoralen-Conjugated Triplex-Forming Oligonucleotides as Antigene Tools Targeting Genome DNA","authors":"Dr. Yu Mikame, Honoka Eshima, Haruki Toyama, Juki Nakao, Misaki Matsuo, Dr. Tsuyoshi Yamamoto, Prof. Yoshiyuki Hari, Prof. Jun A. Komano, Prof. Asako Yamayoshi","doi":"10.1002/cmdc.202300348","DOIUrl":"10.1002/cmdc.202300348","url":null,"abstract":"<p>Psoralen-conjugated triplex-forming oligonucleotides (Ps-TFOs) have been utilized for genome editing and anti-gene experiments for over thirty years. However, the research on Ps-TFOs employing artificial nucleotides is still limited, and their photo-crosslinking properties have not been thoroughly investigated in relation to biological activities. In this study, we extensively examined the photo-crosslinking properties of Ps-TFOs to provide fundamental insights for future Ps-TFO design. We developed novel Ps-TFOs containing 2′-<i>O</i>,4′-<i>C</i>-methylene-bridged nucleic acids (Ps-LNA-mixmer) and investigated their photo-crosslinking properties using stable cell lines that express firefly luciferase constitutively to evaluate the anti-gene activities of Ps-LNA-mixmer. As a result, Ps-LNA-mixmer successfully demonstrated suppression activity, and we presented the first-ever correlation between photo-crosslinking properties and their activities. Our findings also indicate that the photo-crosslinking process is insufficient under cell irradiation conditions (365 nm, 2 mW/cm<sup>2</sup>, 60 min). Therefore, our results highlight the need to develop new psoralen derivatives that are more reactive under cell irradiation conditions.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"18 21","pages":""},"PeriodicalIF":3.4,"publicationDate":"2023-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10229467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2023-09-13DOI: 10.1002/cmdc.202300219
Heng Zhang, Xiao Guo, Di Zhou, Jiatong Wen, Yingzhan Tang, Jian Wang, Prof. Dr. Yang Liu, Prof. Dr. Gang Chen, Prof. Dr. Ning Li
{"title":"Design, Synthesis of (±)-Millpuline A, and Biological Evaluation for the Lung Cell Protective Effects through SRC","authors":"Heng Zhang, Xiao Guo, Di Zhou, Jiatong Wen, Yingzhan Tang, Jian Wang, Prof. Dr. Yang Liu, Prof. Dr. Gang Chen, Prof. Dr. Ning Li","doi":"10.1002/cmdc.202300219","DOIUrl":"10.1002/cmdc.202300219","url":null,"abstract":"<p>In this study, a visible-light-induced intermolecular [2+2] photocycloaddition reaction based on flavonoids was constructed to address the problems of low yield, poor physicochemical properties, and lack of target definition in total synthesis of (±)-millpuline A whose bioactivity remains unknown. As a result, 20 derivatives were synthesized for bioactivity evaluation. Consequently, lung cell protective effects of (±)-millpuline A and compound <b>B13 a</b> were revealed for the first time and the crucial role of stereoconfiguration of the cyclobutane moiety in their protective effects against NNK in normal lung cells was demonstrated. Moreover, through target prediction and experimental verification in MLE-12 cells, SRC was determined to be the target of (±)-millpuline A regarding its protective effect in NNK-induced lung cell injury. Results from RT-Q-PCR and HTRF experiments verified that (±)-millpuline A could repress SRC activity through a transcriptional mechanism but not acting as an inhibitor to directly bind to and thereby inhibit SRC protein. The results in this paper are informative for the further development of visible light-catalyzed cycloaddition of flavonoids and lay a scientific foundation for understanding the bioactivity and underlying mechanism of (±)-millpuline A and other structurally similar natural skeletons.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"18 20","pages":""},"PeriodicalIF":3.4,"publicationDate":"2023-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10234936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2023-09-12DOI: 10.1002/cmdc.202300404
Daniel Zaienne, Laura Isigkeit, Dr. Julian A. Marschner, Silke Duensing-Kropp, Dr. Georg Höfner, Prof. Dr. Daniel Merk
{"title":"Structural Modification of the Natural Product Valerenic Acid Tunes RXR Homodimer Agonism","authors":"Daniel Zaienne, Laura Isigkeit, Dr. Julian A. Marschner, Silke Duensing-Kropp, Dr. Georg Höfner, Prof. Dr. Daniel Merk","doi":"10.1002/cmdc.202300404","DOIUrl":"10.1002/cmdc.202300404","url":null,"abstract":"<p>Retinoid X receptors (RXR) are ligand-sensing transcription factors with a unique role in nuclear receptor signaling as universal heterodimer partners. RXR modulation holds potential in cancer, neurodegeneration and metabolic diseases but adverse effects of RXR activation and lack of selective modulators prevent further exploration as therapeutic target. The natural product valerenic acid has been discovered as RXR agonist with unprecedented preference for RXR subtype and homodimer activation. To capture structural determinants of this activity profile and identify potential for optimization, we have studied effects of structural modification of the natural product on RXR modulation and identified an analogue with enhanced RXR homodimer agonism.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"18 21","pages":""},"PeriodicalIF":3.4,"publicationDate":"2023-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.202300404","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10580428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2023-09-12DOI: 10.1002/cmdc.202300267
Dr. Ilaria D'Agostino, Prof. Susi Zara, Prof. Simone Carradori, Dr. Viviana De Luca, Dr. Clemente Capasso, Dr. Clemens H. M. Kocken, Dr. Anne-Marie Zeeman, Dr. Andrea Angeli, Prof. Fabrizio Carta, Prof. Claudiu T. Supuran
{"title":"Antimalarial Agents Targeting Plasmodium falciparum Carbonic Anhydrase: Towards Artesunate Hybrid Compounds with Dual Mechanism of Action","authors":"Dr. Ilaria D'Agostino, Prof. Susi Zara, Prof. Simone Carradori, Dr. Viviana De Luca, Dr. Clemente Capasso, Dr. Clemens H. M. Kocken, Dr. Anne-Marie Zeeman, Dr. Andrea Angeli, Prof. Fabrizio Carta, Prof. Claudiu T. Supuran","doi":"10.1002/cmdc.202300267","DOIUrl":"10.1002/cmdc.202300267","url":null,"abstract":"<p>Malaria continues to be a major public health challenge worldwide and, as part of the global effort toward malaria eradication, plasmodium carbonic anhydrases (CAs) have recently been proposed as potential targets for malaria treatment. In this study, a series of eight hybrid compounds combining the Artesunate core with a sulfonamide moiety were synthesized and evaluated for their inhibition potency against the widely expressed human (<i>h</i>) CAs I, II and the isoform from <i>P. falciparum</i> (<i>Pf</i>CA). All derivatives demonstrated high inhibition potency against <i>Pf</i>CA, achieving a <i>K<sub>I</sub></i> value in the sub-nanomolar range (0.35 nM). Two Compounds showed a selectivity index of 4.1 and 3.1, respectively, against this protozoan isoform compared to hCA II. Three Derivatives showed no cytotoxic effects on human gingival fibroblasts at 50 μM with a high killing rate against both <i>P. falciparum</i> and <i>P. knowlesi</i> strains with IC<sub>50</sub> in the sub-nanomolar range, providing a wide therapeutic window. Our findings suggest that these compounds may serve as promising leads for developing new antimalarial drugs and warrant further investigation, including activity against antimalarial-resistant strains, mode of action studies, and <i>in vivo</i> efficacy assessment in preclinical mouse models of malaria.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"18 21","pages":""},"PeriodicalIF":3.4,"publicationDate":"2023-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10268327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2023-09-11DOI: 10.1002/cmdc.202300330
Federico Ricci, Dr. Andrea Angeli, Dr. Francesca Mancuso, Prof. Laura De Luca, Prof. Claudiu T. Supuran, Prof. Rosaria Gitto
{"title":"Screening Campaign and Docking Investigations in Identifying New Hit Compounds as Inhibitors of Human Carbonic Anhydrases Expressed In Tumour Cells","authors":"Federico Ricci, Dr. Andrea Angeli, Dr. Francesca Mancuso, Prof. Laura De Luca, Prof. Claudiu T. Supuran, Prof. Rosaria Gitto","doi":"10.1002/cmdc.202300330","DOIUrl":"10.1002/cmdc.202300330","url":null,"abstract":"<p>The tumor-expressed human carbonic anhydrase (hCA) isoforms hCA IX and hCA XII have been extensively studied to develop anticancer agents targeting solid tumors in combined therapy. These CA isoforms are considered key factors in controlling tumor microenvironment (TME) of cancer lines that develop high metastatic activity. Herein, we report the discovery of potent hCA IX/hCA XII inhibitors that were disclosed through a screening campaign on an in-house collection of arylsulfonamides preliminary tested toward other hCAs. Among them, the <i>N</i>-(4-sulfamoylphenyl)naphthalene-2-carboxamide (<b>12</b>) and <i>N</i>-(4-sulfamoylphenyl)-3,4-dihydroisoquinoline-2(1<i>H</i>)-carbothioamide (<b>15</b>) proved to be the most intriguing hCA IX/hCA XII inhibitors displaying favourable selectivity ratios over widespread hCA I and hCA II isoforms. To explore their binding mode, we conducted docking studies that described the poses of the best inhibitors in the catalytic site of hCA IX and hCA XII, thus suggesting the privileged pattern of interactions. These structural findings might further improve the knowledge for a successful identification of new sulfonamides as adjuvant agents in cancer management.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"18 20","pages":""},"PeriodicalIF":3.4,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10205973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2023-09-07DOI: 10.1002/cmdc.202300299
Prof. Stephanie Federico, Margherita Persico, Letizia Trevisan, Chiara Biasinutto, Dr. Giovanni Bolcato, Dr. Veronica Salmaso, Prof. Tatiana Da Ros, Dr. Teresa Gianferrara, Dr. Filippo Prencipe, Sonja Kachler, Prof. Karl-Norbert Klotz, Prof. Sabrina Pacor, Prof. Stefano Moro, Prof. Giampiero Spalluto
{"title":"[1,2,4]Triazolo[1,5-c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines","authors":"Prof. Stephanie Federico, Margherita Persico, Letizia Trevisan, Chiara Biasinutto, Dr. Giovanni Bolcato, Dr. Veronica Salmaso, Prof. Tatiana Da Ros, Dr. Teresa Gianferrara, Dr. Filippo Prencipe, Sonja Kachler, Prof. Karl-Norbert Klotz, Prof. Sabrina Pacor, Prof. Stefano Moro, Prof. Giampiero Spalluto","doi":"10.1002/cmdc.202300299","DOIUrl":"10.1002/cmdc.202300299","url":null,"abstract":"<p>The A<sub>3</sub> adenosine receptor is an interesting target whose role in cancer is controversial. In this work, a structural investigation at the 2-position of the [1,2,4]triazolo[1,5-<i>c</i>]pyrimidine nucleus was performed, finding new potent and selective A<sub>3</sub> adenosine receptor antagonists such as the ethyl 2-(4-methoxyphenyl)-5-(methylamino)-[1,2,4]triazolo[1,5-<i>c</i>]pyrimidine-8-carboxylate (<b>20</b>, DZ123) that showed a K<sub>i</sub> value of 0.47 nM and an exceptional selectivity profile over the other adenosine receptor subtypes. Computational studies were performed to rationalize the affinity and the selectivity profile of the tested compounds at the A<sub>3</sub> adenosine receptor and the A<sub>1</sub> and A<sub>2A</sub> adenosine receptors. Compound <b>20</b> was tested on both A<sub>3</sub> adenosine receptor positive cell lines (CHO-A<sub>3</sub>AR transfected, THP1 and HCT16) and on A<sub>3</sub> negative cancer cell lines, showing no effect in the latter and a pro-proliferative effect at a low concentration in the former. These interesting results pave the way to further investigation on both the mechanism involved and potential therapeutic applications.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"18 21","pages":""},"PeriodicalIF":3.4,"publicationDate":"2023-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10171303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2023-09-07DOI: 10.1002/cmdc.202300245
Dr. Zhipeng Zeng, Shi Chen, Prof. Yongming Chen
{"title":"Zwitterionic Polymer: A New Paradigm for Protein Conjugation beyond PEG","authors":"Dr. Zhipeng Zeng, Shi Chen, Prof. Yongming Chen","doi":"10.1002/cmdc.202300245","DOIUrl":"10.1002/cmdc.202300245","url":null,"abstract":"<p>To render protein drugs more suitable for clinical treatment, PEGylation has been widely used to ameliorate their inherent deficiencies, such as poor stability, rapid elimination in the bloodstream, and high immunogenicity. While increasingly PEGylated protein drugs have been approved by the FDA, the non-degradability of PEG and the emergence of anti-PEG antibodies after injection raise concerns about their cumulative chronic toxicity and long-term therapeutic efficacy. Zwitterionic polymer, with a unique structure containing equal amounts of positively charged and negatively charged groups, shows a different hydration behavior to PEG, which may be a superior PEG alternative for protein conjugation. In this concept review, a series of features beyond that of PEGylated protein exhibited by protein-zwitterionic polymer conjugate are discussed and some suggestions are presented for their future direction.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"18 20","pages":""},"PeriodicalIF":3.4,"publicationDate":"2023-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10169926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2023-09-04DOI: 10.1002/cmdc.202300455
{"title":"Corrigendum: A Study of the Activity of Adamantyl Amines against Mutant Influenza A M2 Channels Identified a Polycyclic Cage Amine Triple Blocker, Explored by Molecular Dynamics Simulations and Solid-State NMR","authors":"","doi":"10.1002/cmdc.202300455","DOIUrl":"10.1002/cmdc.202300455","url":null,"abstract":"<p>The first two lines of the final sentence in the abstract should read: “The triple blocker compound is as long as rimantadine, but <span>can</span> bind and block the V27A M2 channel…” (where ‘can’ replaces ‘could’). In addition, the first two sentences of the final paragraph on page 9 should read: “Using MAS ssNMR we probed the binding of compound <b>61</b> to V27 and L26F M2 using M2(18–60) (M2CD). Compared to very broad peaks in the apo-proteins spectra of both V27 and L26F, upon addition of the drug, a notable enhancement in peak resolution was observed, suggesting that the conformational freedom of the protein was reduced upon drug–protein complex formation with compound <b>61</b> (Figures 2 and 3).”</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"18 20","pages":""},"PeriodicalIF":3.4,"publicationDate":"2023-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10137890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2023-09-01DOI: 10.1002/cmdc.202300461
Dr. Gustavo da Silva, André F. S. Luz, Denise Duarte, Dr. Diana Fontinha, Dr. Vera L. M. Silva, Dr. Filipe A. Almeida Paz, Dr. Ana M. Madureira, Dr. Sandra Sim?es, Dr. Miguel Prudêncio, Dr. Fátima Nogueira, Prof. Artur M. S. Silva, Prof. Rui Moreira
{"title":"Front Cover: Facile Access to Structurally Diverse Antimalarial Indoles Using a One-Pot A3 Coupling and Domino Cyclization Approach (ChemMedChem 17/2023)","authors":"Dr. Gustavo da Silva, André F. S. Luz, Denise Duarte, Dr. Diana Fontinha, Dr. Vera L. M. Silva, Dr. Filipe A. Almeida Paz, Dr. Ana M. Madureira, Dr. Sandra Sim?es, Dr. Miguel Prudêncio, Dr. Fátima Nogueira, Prof. Artur M. S. Silva, Prof. Rui Moreira","doi":"10.1002/cmdc.202300461","DOIUrl":"https://doi.org/10.1002/cmdc.202300461","url":null,"abstract":"<p><b>The Front Cover</b> depicts a female <i>Anopheles</i> spp. mosquito, the vector of <i>Plasmodium falciparum</i> and perhaps the most iconic image associated with the fight against malaria, which inspects the structure of a new indole scaffold with promising activity against blood-stage malaria parasites, under the moonlight (the vector has a nocturnal feeding habit, where transmission occurs). The highlighted lead compound is rising to the moon and above blood-stage parasitic forms of <i>P. falciparum</i>, in which this new scaffold revealed preferential inhibitory activity. The copyrighted <i>Anopheles</i> picture is used with the permission of Prof. Laurence J. Zwiebel. Cover design by Natália Marques Mota. More information can be found in the Research Article by Gustavo da Silva, Rui Moreira et al.<figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure>\u0000 </p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"18 17","pages":""},"PeriodicalIF":3.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.202300461","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"6049977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}